Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Tumor Protein D52-Like 2 (TPD52L2) (Middle Region) Peptid

TPD52L2 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN5672656

Kurzübersicht für Tumor Protein D52-Like 2 (TPD52L2) (Middle Region) Peptid (ABIN5672656)

Target

TPD52L2 (Tumor Protein D52-Like 2 (TPD52L2))

Spezies

Human

Quelle

  • 4
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequenz

    GEWNEKVTQS DLYKKTQETL SQAGQKTSAA LSTVGSAISR KLGDMRNSAT

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti- TPD52L2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    TPD52L2 (Tumor Protein D52-Like 2 (TPD52L2))

    Hintergrund

    This gene encodes a member of the tumor protein D52-like family. These proteins are characterized by an N-terminal coiled-coil motif that is used to form homo- and heteromeric complexes with other tumor protein D52-like proteins. Expression of this gene may be a marker for breast cancer and acute lymphoblastic leukemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 12.

    Alias Symbols: D54, TPD54

    Protein Size: 229

    Gen-ID

    7165

    NCBI Accession

    NM_001243892, NP_001230821
Sie sind hier:
Chat with us!